First Study of the Safety, Tolerability, and Pharmacokinetics of CP-724,714 in Patients with Advanced Malignant Solid HER2-Expressing Tumors
暂无分享,去创建一个
K. Gelmon | A. Tolcher | L. Denis | C. Britten | P. Munster | D. Slamon | S. Moulder | M. Mita | S. Minton | S. Letrent | F. Guo